Medical

Steroid Equivalent Dose Converter

Convert between hydrocortisone, prednisone, methylprednisolone, dexamethasone and other glucocorticoids by equipotent dose. Anti-inflammatory potency, mineralocorticoid activity and duration of action included.

All equivalents from 20 mg Hydrocortisone

DrugDoseAnti-inf.
Hydrocortisone (source)20 mg×1
Cortisone25 mg×0.8
Prednisone5 mg×4
Prednisolone5 mg×4
Methylprednisolone4 mg×5
Triamcinolone4 mg×5
Dexamethasone0.75 mg×25
Betamethasone0.6 mg×25

Hydrocortisone reference

Anti-inflammatory potency×1
Mineralocorticoid potency×1
Duration of actionShort (8–12h)

Frequently asked questions

Standard equipotent ratios put 5 mg of prednisone at roughly 20 mg of hydrocortisone, so 1 mg of prednisone corresponds to about 4 mg of hydrocortisone (anti-inflammatory equivalence only). Prednisone is roughly four times more potent than hydrocortisone on an anti-inflammatory basis, but hydrocortisone also has stronger mineralocorticoid activity, so the two drugs are not interchangeable when mineralocorticoid effect matters (e.g. adrenal insufficiency).

No. On the consensus equipotent scale, 4 mg of methylprednisolone is roughly equivalent to 0.75 mg of dexamethasone — dexamethasone is about 5–6 times more potent than methylprednisolone milligram-for-milligram. The Endocrine Society and most pharmacology references give dexamethasone an anti-inflammatory potency of about 25 relative to hydrocortisone at 1 (some texts cite 25–30). Switching mg-for-mg between these two drugs without converting first leads to substantial over- or under-dosing.

Equipotent tables built on systemic anti-inflammatory potency are derived from oral or intravenous pharmacology. Topical, inhaled, intra-articular and ophthalmic glucocorticoids have very different absorption, vehicle, and local-tissue activity profiles — beclometasone inhaled and beclometasone systemic are not directly comparable. NCBI Endotext and Czock 2005 list separate potency frameworks for topical/inhaled routes, which the calculator deliberately does not mix in.

There is no single answer — choice depends on the indication. Short-acting agents (hydrocortisone, cortisone) are often preferred for replacement therapy in adrenal insufficiency because their pharmacokinetics mimic the natural cortisol curve. Intermediate-acting agents (prednisone, prednisolone, methylprednisolone) are common for chronic inflammatory disease where once-daily dosing is convenient. Long-acting agents (dexamethasone, betamethasone) have the highest HPA-axis suppression per mg and are usually reserved for specific indications such as cerebral oedema, antenatal lung maturation, or short anti-emetic courses. Equivalent doses, monitoring, and tapering schedules are detailed in Liu 2013.

The equipotent ratios are the same in paediatric practice — 4 mg of methylprednisolone is still equivalent to about 5 mg of prednisone in a child. What changes is dose selection: paediatric corticosteroid dosing is computed per kilogram of body weight or per square metre of body surface area, not by adult flat doses. This tool converts a given dose between drugs; it does not select the appropriate paediatric dose. Use the BSA calculator and a paediatric dose reference for that step.

Help us improve this calculator

What's missing or wrong? What would make this more useful for you? Every suggestion lands in our inbox.

We don't share emails. Replies come from hello@liphyr.com.

Related tools